Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors

Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors

Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Levin, Jeremy Ian, Du, Mila Ti
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Levin, Jeremy Ian
Du, Mila Ti
description Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07485667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07485667</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074856673</originalsourceid><addsrcrecordid>eNqNjEEKwjAQAHPxIOof9gOCoLZeiyg-QLzKmmztwjYpmy00v9eCD_A0hxlm6R6NJytCkT2gFoE8SpsiGkFXgqYJ-9l4DmDoCTAG6NGUJ-jJUCQNmow4Yibg2PGLLWleu0WLkmnz48rB9XI_37ZjHr7vaPn5Vpyxqw-nY1XV-z-SD0K1O3w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors</title><source>USPTO Issued Patents</source><creator>Levin, Jeremy Ian ; Du, Mila Ti</creator><creatorcontrib>Levin, Jeremy Ian ; Du, Mila Ti ; Wyeth Holdings Corporation</creatorcontrib><description>Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7485667$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7485667$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Levin, Jeremy Ian</creatorcontrib><creatorcontrib>Du, Mila Ti</creatorcontrib><creatorcontrib>Wyeth Holdings Corporation</creatorcontrib><title>Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors</title><description>Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjEEKwjAQAHPxIOof9gOCoLZeiyg-QLzKmmztwjYpmy00v9eCD_A0hxlm6R6NJytCkT2gFoE8SpsiGkFXgqYJ-9l4DmDoCTAG6NGUJ-jJUCQNmow4Yibg2PGLLWleu0WLkmnz48rB9XI_37ZjHr7vaPn5Vpyxqw-nY1XV-z-SD0K1O3w</recordid><startdate>20090203</startdate><enddate>20090203</enddate><creator>Levin, Jeremy Ian</creator><creator>Du, Mila Ti</creator><scope>EFH</scope></search><sort><creationdate>20090203</creationdate><title>Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors</title><author>Levin, Jeremy Ian ; Du, Mila Ti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074856673</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Levin, Jeremy Ian</creatorcontrib><creatorcontrib>Du, Mila Ti</creatorcontrib><creatorcontrib>Wyeth Holdings Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Levin, Jeremy Ian</au><au>Du, Mila Ti</au><aucorp>Wyeth Holdings Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors</title><date>2009-02-03</date><risdate>2009</risdate><abstract>Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07485667
source USPTO Issued Patents
title Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T10%3A17%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Levin,%20Jeremy%20Ian&rft.aucorp=Wyeth%20Holdings%20Corporation&rft.date=2009-02-03&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07485667%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true